Tech Company Financing Transactions
TrialJectory Funding Round
TrialJectory, based in New York, secured $2.7 million in funding from Contour Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
12/19/2019
Transaction Type
Venture Equity
Amount
$2,700,000
Round
Seed
Investors
Contour Venture Partners (Lead Investor)
Proceeds Purpose
Proceeds from the financing will expedite the growth of TrialJectory's platform, which includes adding more clinical trials for different cancer types and expanding the Company's outreach across the medical, pharmaceutical and patient communities.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
119W 24 St.
New York, NY 10019
USA
New York, NY 10019
USA
Phone
Undisclosed
Website
Email Address
Overview
Trialjectory.com is an AI-based trial matching platform that uses self-reported clinical information to facilitate clinical trial search, matching and enrollment by cancer patients and their physicians.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tzvia Bader
Co-Founder
Avital Gaziel
VP - Product Management
Noam Geva
Browse more venture capital transactions:
Prev: 12/19/2019: Humm Systems venture capital transaction
Next: 12/19/2019: Canvas Recruiting venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. All VC database entries reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs